Corcept Therapeutics CORT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $109.99M+21.1% | $121.75M-5.4% | $125.14M-8.9% | $102.75M-20.1% | $90.82M-39.4% | ||
| $229.45M-1.5% | $251.66M-1.6% | $296.55M+22.0% | $239.48M-30.5% | $232.94M-10.8% | ||
| $1.25M+25.0% | —— | —— | —— | $1M— | ||
| $39.07M-36.8% | $59.79M+10.8% | $69.63M+16.6% | $64.57M+19.9% | $61.82M+0.5% | ||
| $14.51M+1,144% | $11.09M+210% | $12M+54.6% | $7.99M-5.4% | $1.17M-85.1% | ||
| $35.89M-9.3% | $40.66M+85.8% | $37.47M+98.5% | $24.04M-5.7% | $39.55M+65.5% | ||
| $4.2M— | $14.6M+284% | $14.2M— | —— | —— | ||
| $426.03M-2.8% | $485.46M+2.9% | $541.13M+15.9% | $443.11M-21.0% | $438.5M-12.9% | ||
| $3.17M+24.7% | $1.89M-29.7% | $2.09M-28.5% | $2.35M+59.5% | $2.54M+1,902% | ||
| 8.3%-0.2% | 458,300,000%-74,100,000% | 8.5%0.0% | 8.5%0.0% | 8.5%+0.5% | ||
| $5.15M-22.0% | $5.15M-22.0% | $8.05M+15.4% | $8.3M+19.7% | $6.61M+3.5% | ||
| $490.93M-10.8% | $511.7M-10.8% | $499.49M-4.2% | $484.56M+5.4% | $550.65M— | ||
| $814.88M-3.7% | $836.65M-0.5% | $823.61M+5.0% | $801.72M+12.2% | $846.46M+29.0% | ||
| $33.31M+19.2% | $40.44M+163% | $34.45M+85.4% | $23.53M+20.7% | $27.95M+123% | ||
| $80.16M-9.8% | $90.6M-0.1% | $108.45M— | $91.07M— | $88.88M— | ||
| $1.63M+65.3% | $1.08M+30.8% | $1.05M+143% | $1.02M+2,211% | $984K+1,195% | ||
| $3.7M-15.9% | $4.1M0.0% | —— | —— | $4.4M— | ||
| $149.19M+4.3% | $166.09M+18.0% | $172.27M+36.5% | $144.66M+43.6% | $143.07M+47.2% | ||
| $8.01M+36.9% | $5.02M-17.8% | $5.31M-16.5% | $5.59M-0.7% | $5.85M— | ||
| $9.64M+41.0% | $6.11M-12.0% | $6.36M-6.4% | $6.61M+16.5% | $6.84M+8,893% | ||
| $176.89M+8.4% | $188.85M+17.3% | $191.71M+31.8% | $165.93M+40.2% | $163.17M+51.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $141K+2.9% | $140K+2.9% | $139K+3.0% | $138K+3.0% | $137K+3.0% | ||
| $1B+16.1% | $968.6M+16.4% | $933.61M+15.8% | $900.86M+15.3% | $862.87M+13.8% | ||
| $611.63M+8.4% | $643.39M+18.3% | $619.1M+20.7% | $599.43M+28.7% | $564.28M+31.1% | ||
| $918K+32.7% | $2.26M+1,143% | $2.34M+49.0% | $2.29M+2,627% | $692K+168% | ||
| $976.69M+31.2% | $966.59M+38.8% | $923.29M+35.3% | $866.93M+33.2% | $744.69M+16.2% | ||
| $637.99M-6.6% | $647.81M-4.7% | $631.9M-1.1% | $635.79M+6.6% | $683.29M+24.7% | ||
| $814.88M-3.7% | $836.65M-0.5% | $823.61M+5.0% | $801.72M+12.2% | $846.46M+29.0% | ||
| $229.45M-1.5% | $251.66M-1.6% | $296.55M+22.0% | $239.48M-30.5% | $232.94M-10.8% | ||
| $6.38M-74.3% | $7.1M+16.8% | $6M+31.0% | $7.47M-18.1% | $24.87M+35.5% | ||
| $177.26M-28.5% | $160.27M-27.1% | $102.56M-38.7% | $172.78M+795% | $248.04M+516% | ||
| $5.15M-22.0% | $5.15M-22.0% | $8.05M+15.4% | $8.3M+19.7% | $6.61M+3.5% | ||
| $7.2M+39.8% | $4.58M-13.9% | $4.78M-13.2% | $4.96M-12.7% | $5.15M+8,338% | ||
| $181.56M+25.7% | $168.2M+28.5% | $153M+20.7% | $162.23M+45.0% | $144.45M+47.6% | ||
| $177.26M-28.5% | $160.27M-27.1% | $102.56M-38.7% | $172.78M+795% | $248.04M+516% | ||
| $7.2M+39.8% | $4.58M-13.9% | $4.78M-13.2% | $4.96M-12.7% | $5.15M+8,338% | ||
| $5.15M-22.0% | $5.15M-22.0% | $8.05M+15.4% | $8.3M+19.7% | $6.61M+3.5% | ||
| $7.2M+39.8% | $4.58M-13.9% | $4.78M-13.2% | $4.96M-12.7% | $5.15M+8,338% | ||
| $5.15M-22.0% | $5.15M-22.0% | $8.05M+15.4% | $8.3M+19.7% | $6.61M+3.5% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $13.59M+224% | $10.61M+217% | $8.92M+125% | $7.04M+99.2% | $4.2M+25.6% | ||
| $80.16M-9.8% | $90.6M-0.1% | $108.45M+36.5% | $91.07M+53.7% | $88.88M+48.8% | ||
| $34.09M+35.0% | $33.95M+0.3% | —— | —— | $25.26M+1.8% | ||
| $80.16M-9.8% | $90.6M-0.1% | $108.45M+36.5% | $91.07M+53.7% | $88.88M+48.8% | ||
| $1.69M+49.3% | —— | $382K— | $764K— | $1.14M+1,374% | ||
| $2.78M+73.8% | —— | $1.6M+3.0% | $1.6M+3.0% | $1.6M— | ||
| $1.45M-14.3% | —— | $1.7M+3.0% | $1.7M+3.0% | $1.7M— | ||
| $2.78M+73.8% | —— | $1.6M+3.0% | $1.6M+3.0% | $1.6M— | ||
| $2.86M+73.8% | —— | $1.65M+3.0% | $1.65M+3.0% | $1.65M— | ||
| $1.45M-14.3% | —— | $1.7M+3.0% | $1.7M+3.0% | $1.7M— | ||
| $2.7M+73.9% | —— | $1.55M+12.2% | $1.55M+12.2% | $1.55M— | ||
| $11.48M+35.3% | —— | $7.73M-11.5% | $8.11M-7.1% | $8.49M+10,919% | ||
| $1.84M+11.8% | —— | $1.37M-29.2% | $1.51M-27.6% | $1.65M+164,900% | ||
| $2.86M+233% | —— | $1.65M+3.0% | $1.65M+3.0% | $860K— | ||
| $1.45M-14.3% | —— | $1.7M+3.0% | $1.7M+3.0% | $1.7M— | ||
| $13.59M+224% | $10.61M+217% | $8.92M+125% | $7.04M+99.2% | $4.2M+25.6% | ||
| $9.64M+41.0% | $6.11M-12.0% | $6.36M-6.4% | $6.61M+16.5% | $6.84M+8,893% | ||
| $1B+16.1% | $968.6M+16.4% | $933.61M+15.8% | $900.86M+15.3% | $862.87M+13.8% | ||
| $20.87M-42.7% | $37.4M-10.4% | $35.28M+28.0% | $26.28M+51.1% | $36.42M+228% | ||
| $33.56M-24.1% | $35.68M-14.2% | $53.34M+37.5% | $50.87M+60.7% | $44.23M+60.6% | ||
| $15.33M+7.6% | $15.18M+7.8% | $14.13M+10.0% | $15.68M+31.3% | $14.25M+31.1% | ||
| $5.24M+188% | $5.24M+188% | $2.48M-10.5% | $2.48M-14.6% | $1.82M— | ||
| $490.93M-10.8% | $511.7M-10.8% | —— | —— | $550.65M— | ||
| $4.41M+2.2% | $5.06M+12.6% | $6.01M+5.3% | $4.4M-47.2% | $4.32M— | ||
| $27.4M+76.4% | $23.96M+49.8% | $24.35M+54.0% | $20.27M+20.6% | $15.53M+3.3% | ||
| $14.69M+72.9% | $9.41M+14.7% | $8.6M+6.9% | $6.72M-19.5% | $8.5M+18.0% | ||
| $894K— | $847K— | $1.55M— | $1.75M— | —— | ||
| $11.81M+67.9% | $13.7M+75.9% | $14.2M+82.9% | $11.8M+39.6% | $7.04M-1.4% | ||
| $11.48M+35.3% | —— | $7.73M-11.5% | $8.11M-7.1% | $8.49M+10,919% | ||
| $1.84M+11.8% | —— | $1.37M-29.2% | $1.51M-27.6% | $1.65M+164,900% | ||
| —— | 40.9K— | —— | —— | —— | ||
| $4.37M— | $2.56M— | —— | —— | —— | ||
| $0— | —— | $0— | $0— | $0— | ||
| —— | $1M— | —— | —— | —— | ||
| $0.08-2.4% | —— | $0.090.0% | $0.090.0% | $0.09+6.3% | ||
| $12.14M+202% | $6.91M+71.0% | $10.91M+49.4% | $6.88M+30.0% | $4.03M+279% | ||
| $19.86M+132% | $23.26M+145% | $22.98M+295% | $9.69M+88.4% | $8.55M+54.3% | ||
| $10.2M— | —— | —— | —— | —— | ||
| 1.5K— | —— | —— | —— | —— | ||
| $10.2M— | —— | —— | —— | —— | ||
| $1.69M+49.3% | —— | $382K— | $764K— | $1.14M+1,374% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corcept Therapeutics's total assets?
- Corcept Therapeutics (CORT) holds $814.9M in total assets, down 3.7% year over year.
- How much debt does Corcept Therapeutics have?
- Corcept Therapeutics carries $9.6M in total debt against $638.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Corcept Therapeutics have?
- Corcept Therapeutics holds $110.0M in cash and equivalents.
- Can Corcept Therapeutics cover its short-term obligations?
- Its current ratio is 2.86 — current assets exceed current liabilities.
- Where does Corcept Therapeutics's balance sheet data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
